Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-1995 | 06-1995 | 03-1995 | 12-1994 | 09-1994 | |
| Sales | 1,631,900 | 1,614,800 | 1,717,300 | 1,548,400 | 1,507,300 |
| Cost of Goods | 419,700 | 459,400 | 512,500 | 460,400 | 451,400 |
| Gross Profit | 1,212,200 | 1,155,400 | 1,204,800 | 1,088,000 | 1,055,900 |
| Operating Expenses | 705,400 | 697,200 | 644,400 | 667,400 | 580,300 |
| Operating Income | 507,500 | 458,600 | 560,900 | 421,000 | 476,000 |
| Interest Expense | 75,600 | 72,300 | 66,200 | 53,100 | 15,300 |
| Other Income | 5,400 | 50,300 | 33,200 | 10,600 | -33,900 |
| Pre-tax Income | 437,300 | 436,600 | 527,900 | 378,500 | 426,800 |
| Income Tax | 126,800 | 126,600 | 153,100 | 108,900 | 131,200 |
| Net Income Continuous | 310,500 | 310,000 | 374,800 | 269,600 | 295,600 |
| Net Income Discontinuous | 917,500 | 17,100 | 18,400 | 20,500 | 23,100 |
| Net Income | $1,228,000 | $327,100 | $393,200 | $290,100 | $318,700 |
| EPS Basic Total Ops | 1.07 | 0.28 | 0.34 | 0.25 | 0.28 |
| EPS Basic Continuous Ops | 0.27 | 0.27 | 0.32 | 0.23 | 0.26 |
| EPS Basic Discontinuous Ops | 0.80 | 0.01 | 0.02 | 0.02 | 0.02 |
| EPS Diluted Total Ops | 1.07 | 0.28 | 0.34 | 0.25 | 0.28 |
| EPS Diluted Continuous Ops | 0.27 | 0.27 | 0.32 | 0.23 | 0.26 |
| EPS Diluted Discontinuous Ops | 0.80 | 0.01 | 0.02 | 0.02 | 0.02 |
| EBITDA(a) | $507,500 | $458,600 | $560,900 | $421,000 | $476,000 |